Polaryx Therapeutics, Inc. Common Stock (PLYX) — Financial Flexibility Index
Polaryx Therapeutics, Inc. Common Stock (PLYX) has a Financial Flexibility Index of -1.57x as of June 2026. Free cash flow of $-1.37 Million (operating CF $-1.37 Million minus capex $0.00) represents -2% of total liabilities ($873.00K). Check Polaryx Therapeutics, Inc. Common Stock (PLYX) tangible net worth to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Polaryx Therapeutics, Inc. Common Stock Financial Flexibility Index (2023–2025)
Historical Financial Flexibility Index trend for Polaryx Therapeutics, Inc. Common Stock across 3 annual periods. For the full cash flow conversion analysis, see PLYX cash flow metrics.
Annual Financial Flexibility Index for Polaryx Therapeutics, Inc. Common Stock (2023–2025)
Year-by-year free cash flow to debt coverage for Polaryx Therapeutics, Inc. Common Stock. Explore how well can Polaryx Therapeutics, Inc. Common Stock service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.61x | $-3.94 Million | $-3.94 Million | $855.00K | ▲ +48.2% |
| 2024 | -8.90x | $-2.57 Million | $-2.57 Million | $289.00K | ▼ -5241.9% |
| 2023 | -0.17x | $-173.00K | $-173.00K | $1.04 Million | — |